Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Bionik Laboratories Corp. (BNKL) had Return on Equity of 301.48% for the most recently reported fiscal year, ending 2023-03-31.
| Income Statement Financials | |
$1.81M |
|
$-4.95M |
|
$0.82M |
|
$0.99M |
|
$6.63M |
|
$-4.83M |
|
$-0.12M |
|
$-4.95M |
|
$-4.95M |
|
$-4.95M |
|
$-4.95M |
|
$-4.95M |
|
$-4.95M |
|
$-4.83M |
|
$-4.76M |
|
6.90M |
|
6.90M |
|
$-0.72 |
|
$-0.72 |
|
| Balance Sheet Financials | |
$2.78M |
|
$0.19M |
|
$0.58M |
|
$3.36M |
|
$2.31M |
|
$2.16M |
|
$2.69M |
|
$5.00M |
|
$-1.64M |
|
$-1.77M |
|
$-1.64M |
|
6.99M |
|
| Cash Flow Statement Financials | |
$-3.39M |
|
$-0.22M |
|
$2.05M |
|
$1.99M |
|
$0.43M |
|
$-1.56M |
|
$0.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.20 |
|
-- |
|
-- |
|
4.18 |
|
-1.31 |
|
54.83% |
|
-267.29% |
|
-267.29% |
|
-263.79% |
|
-273.99% |
|
-273.99% |
|
$-3.39M |
|
-- |
|
-- |
|
-- |
|
0.54 |
|
0.79 |
|
3.98 |
|
91.61 |
|
|
Return on Equity |
301.48% |
278.78% |
|
-147.11% |
|
-960.01% |
|
$-0.23 |
|
$-0.49 |
|
$-0.49 |
|